Biotech Investing AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO
Biotech Investing UPLIZNA® IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE
Biotech Investing UPLIZNA® SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS
SAGA Metals Extends Claims at the Radar Ti-V-Fe Project --Securing the Entire Titanomagnetite-Bearing Intrusion
Significant intercepts of gold and copper show Golden Eye emerging as a highly promising new resource prospect
Alvopetro Announces an Operational Update, Q1 2025 Financial Results and Details for our Upcoming AGM
